Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Obstetrics

What BP Medications Are Safe During Preeclampsia?

At a Glance

Treating high blood pressure during preeclampsia is essential to prevent severe complications like maternal stroke and placental abruption. First-line medications, including labetalol, nifedipine, and methyldopa, are proven safe and effective for protecting both the mother and the developing baby.

Yes, certain blood pressure medications are very safe to take during pregnancy and are critical for protecting both you and your baby. It is completely normal to be hesitant about taking any medication while expecting. However, when dealing with preeclampsia, leaving high blood pressure untreated is far more dangerous than the medications used to control it. First-line medications—most commonly labetalol and nifedipine—have a long, proven track record of safety during pregnancy [1][2]. Taking these medications as prescribed directly protects you from severe complications and helps ensure your baby continues to grow safely in a stable environment.

Why Treatment is Essential

Preeclampsia places significant stress on your blood vessels and your heart. When maternal blood pressure climbs too high and remains uncontrolled, it creates dangerous risks for both the mother and the baby [3][4].

For the mother, severe spikes in blood pressure can lead to life-threatening complications, such as maternal stroke [5][6]. For the baby, uncontrolled high blood pressure can lead to placental abruption—a serious condition where the placenta prematurely separates from the uterine wall, cutting off the baby’s oxygen and nutrient supply [7][8]. Untreated severe high blood pressure in preeclampsia is associated with a higher risk of fetal distress and stillbirth [9][10].

By bringing your blood pressure down to safer levels, these medications significantly reduce the risk of severe maternal and neonatal harm [11][12]. Current guidelines often target blood pressures below 140/90 mmHg, though your personal target may vary slightly depending on your specific medical history and whether you had chronic hypertension before pregnancy [11].

The Safest Medications for You and Your Baby

Decades of clinical research and practice have established a standard set of “first-line” blood pressure medications (antihypertensives) that are safe for expectant mothers [1][2]. These medications do not cause birth defects and are effective at keeping your blood pressure stable. The most commonly prescribed options include:

  • Labetalol: A type of beta-blocker that slows the heart rate and relaxes blood vessels. It is widely used both as a daily pill and as an IV medication in emergency settings [2][13].
  • Nifedipine: A calcium channel blocker that relaxes the muscle in the walls of your blood vessels to lower pressure. Like labetalol, it is highly effective and safe for the baby [14][2].
  • Methyldopa: A medication that works through the central nervous system to relax blood vessels. It has been used safely in pregnancy for decades [13].

Important Warning: Not all blood pressure medications are safe during pregnancy. Medications commonly taken before pregnancy, such as ACE inhibitors (like lisinopril) and ARBs, are strictly avoided because they can cause severe harm to the developing baby [11][10]. Always verify your prescriptions with your obstetrician.

What to Expect: Side Effects and Symptom Overlap

Like any medication, these first-line treatments can cause side effects. Labetalol may cause dizziness or fatigue, while nifedipine can cause flushing or headaches [14][13].

A crucial note on headaches: Nifedipine can sometimes cause a mild headache. However, a severe headache is also a major red-flag symptom of worsening preeclampsia [3]. If you develop a severe headache, do not assume it is just a side effect of your medication. You should always contact your doctor or go to obstetric triage to be evaluated immediately.

If your blood pressure reading remains high despite taking your medication, do not take an extra dose without instruction. Instead, rest for 15 minutes and retake your blood pressure. If it remains above the upper limits set by your doctor (often \geq 160/110 mmHg), this is considered a medical emergency, and you should seek immediate care to prevent complications [11].

The Risk vs. Benefit Balance

When deciding whether to take medication, it helps to look at the big picture. Preeclampsia is driven by placental dysfunction that restricts blood flow [15][16]. This placental insufficiency is a primary cause of poor fetal growth, known clinically as fetal growth restriction [17][18].

It is a common misconception that lowering the mother’s blood pressure might reduce blood flow to the baby. In reality, controlling dangerous blood pressure spikes protects the fragile blood vessels of the placenta. Keeping your blood pressure in a safe range stabilizes the environment for your baby and fundamentally protects both of your lives [11][19].

What Happens After Delivery?

The risk of preeclampsia does not end immediately when the baby is born. The period surrounding delivery and the postpartum window are the times of highest risk for a maternal stroke, in large part due to shifts in blood volume and clotting factors [5][6].

For this reason, postpartum follow-up is a critical part of your care [20]. You may need to continue taking your blood pressure medication for several weeks after delivery until your body’s systems recover and your blood pressure returns to a healthy baseline.

Common questions in this guide

What blood pressure medications are safe to take during preeclampsia?
First-line medications proven safe during pregnancy include labetalol, nifedipine, and methyldopa. These medications effectively lower blood pressure without causing birth defects.
Will taking blood pressure medication reduce blood flow to my baby?
No, controlling dangerous blood pressure spikes actually protects the fragile blood vessels of the placenta. Keeping your blood pressure in a safe range stabilizes the environment, ensuring your baby continues to receive the necessary oxygen and nutrients.
Are ACE inhibitors safe to take during pregnancy?
No. Blood pressure medications like ACE inhibitors and ARBs are strictly avoided during pregnancy because they can cause severe harm to the developing baby. Always verify any existing prescriptions with your obstetrician.
How can I tell if my headache is a medication side effect or worsening preeclampsia?
While medications like nifedipine can cause mild headaches, a severe headache is a major warning sign of worsening preeclampsia. If you develop a severe headache, you should seek immediate medical evaluation at obstetric triage rather than assuming it is a simple side effect.
Do I need to keep taking blood pressure medicine after my baby is born?
Yes, you may need to continue taking your medication for several weeks postpartum. The period surrounding delivery is a high-risk time for maternal stroke, making continued blood pressure monitoring and treatment essential until your body recovers.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my specific target blood pressure range, and at what exact reading should I call the triage line or go to the hospital?
  2. 2.If I experience a headache after taking my medication, how can I tell if it is a normal side effect or a warning sign of worsening preeclampsia?
  3. 3.How often will we monitor the baby's growth and well-being while I am taking this medication?
  4. 4.What should I do if I throw up my medication shortly after taking it?
  5. 5.Will I need to continue taking this blood pressure medication after I deliver my baby, and how will we monitor my blood pressure postpartum?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal.

    Peres GM, Mariana M, Cairrão E

    Journal of cardiovascular development and disease 2018; (5(1)) doi:10.3390/jcdd5010003.

    PMID: 29367581
  2. 2

    Focused Update on Pharmacologic Management of Hypertensive Emergencies.

    Watson K, Broscious R, Devabhakthuni S, Noel ZR

    Current hypertension reports 2018; (20(7)):56 doi:10.1007/s11906-018-0854-2.

    PMID: 29884955
  3. 3

    Early Mortality, Cardiovascular, and Renal Diseases in Women's Lives Following Hypertensive Disorders of Pregnancy: The Prospective Nationwide Study CONCEPTION.

    Lailler G, Grave C, Gabet A, et al.

    Journal of the American Heart Association 2024; (13(8)):e033252 doi:10.1161/JAHA.123.033252.

    PMID: 38563390
  4. 4

    Cardiac dysfunction during adverse maternal outcomes in hypertensive disorders of pregnancy.

    Giorgione V, Kitt J, Leeson P, et al.

    Acta obstetricia et gynecologica Scandinavica 2026; (105(2)):280-287 doi:10.1111/aogs.70103.

    PMID: 41250558
  5. 5

    Stroke in Pregnancy: An Update.

    Camargo EC, Feske SK, Singhal AB

    Neurologic clinics 2019; (37(1)):131-148 doi:10.1016/j.ncl.2018.09.010.

    PMID: 30470272
  6. 6

    Infection During Delivery Hospitalization and Risk of Readmission for Postpartum Stroke.

    Miller EC, Wen T, Elkind MSV, et al.

    Stroke 2019; (50(10)):2685-2691 doi:10.1161/STROKEAHA.119.025970.

    PMID: 31412756
  7. 7

    Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association.

    Parikh NI, Gonzalez JM, Anderson CAM, et al.

    Circulation 2021; (143(18)):e902-e916 doi:10.1161/CIR.0000000000000961.

    PMID: 33779213
  8. 8

    Pregnancy complications and later life women's health.

    McNestry C, Killeen SL, Crowley RK, McAuliffe FM

    Acta obstetricia et gynecologica Scandinavica 2023; (102(5)):523-531 doi:10.1111/aogs.14523.

    PMID: 36799269
  9. 9

    Hypertensive Disorders of Pregnancy: Overview and Current Recommendations.

    Folk DM

    Journal of midwifery & women's health 2018; (63(3)):289-300 doi:10.1111/jmwh.12725.

    PMID: 29764001
  10. 10

    Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management.

    Magee LA, Smith GN, Bloch C, et al.

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2022; (44(5)):547-571.e1 doi:10.1016/j.jogc.2022.03.002.

    PMID: 35577426
  11. 11

    Nonsevere hypertensive disorders of pregnancy and oral antihypertensive medications: an argument in favor of use.

    Martinez-King LC, Savitsky LM, Rose S, Albright C

    American journal of obstetrics & gynecology MFM 2025; (7(1S)):101561 doi:10.1016/j.ajogmf.2024.101561.

    PMID: 39603527
  12. 12

    Decreasing Time to Treatment in Women With Hypertensive Disorders of Pregnancy in a High-Volume Hospital Obstetric Triage Setting.

    Elischer MH, Schaeffer A

    Journal of obstetric, gynecologic, and neonatal nursing : JOGNN 2026; (55(3)):300-309 doi:10.1016/j.jogn.2025.11.006.

    PMID: 41389840
  13. 13

    Current best practice in the management of hypertensive disorders in pregnancy.

    Townsend R, O'Brien P, Khalil A

    Integrated blood pressure control 2016; (9()):79-94 doi:10.2147/IBPC.S77344.

    PMID: 27555797
  14. 14

    Oral Nifidepine versus IV labetalol in severe preeclampsia: A randomized control trial.

    Wasim T, Agha S, Saeed K, Riaz A

    Pakistan journal of medical sciences 2020; (36(6)):1147-1152 doi:10.12669/pjms.36.6.2591.

    PMID: 32968371
  15. 15

    Total and Free Placental Growth Factor Levels During Preeclampsia and Fetal Growth Restriction.

    Jungelson A, Ridoux A, Barthe M, et al.

    Hypertension (Dallas, Tex. : 1979) 2025; (82(5)):883-893 doi:10.1161/HYPERTENSIONAHA.125.24736.

    PMID: 40171652
  16. 16

    Preeclampsia and the Kidney: Pathophysiology and Clinical Implications.

    Dines V, Suvakov S, Kattah A, et al.

    Comprehensive Physiology 2023; (13(1)):4231-4267 doi:10.1002/cphy.c210051.

    PMID: 36715282
  17. 17

    Timing and Severity of Fetal Growth Restriction Diagnosis and Association with Perinatal Morbidity.

    Bui LN, Ahluwalia S, Ogu NQ, et al.

    American journal of perinatology 2025; doi:10.1055/a-2764-2151.

    PMID: 41397467
  18. 18

    Diagnosis of mid-second trimester fetal growth restriction and associated outcomes.

    Lesser HT, D'Adamo C, O'Reilly G, et al.

    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2022; (35(25)):10168-10172 doi:10.1080/14767058.2022.2122042.

    PMID: 36100267
  19. 19

    The hypertensive disorders of pregnancy (29.3).

    Magee LA, Pels A, Helewa M, et al.

    Best practice & research. Clinical obstetrics & gynaecology 2015; (29(5)):643-57.

    PMID: 26141795
  20. 20

    Hypertension in pregnancy: Pathophysiology and treatment.

    Braunthal S, Brateanu A

    SAGE open medicine 2019; (7()):2050312119843700 doi:10.1177/2050312119843700.

    PMID: 31007914

This page provides educational information about blood pressure medications during preeclampsia. It does not replace professional medical advice; always consult your obstetrician before starting, stopping, or adjusting any medication during pregnancy.

Get notified when new evidence is published on Preeclampsia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.